what is compounded semaglutide vs semaglutide vs. Wegovy Ozempic vs Compounded Semaglutide: Key

Weight Loss Current FDA label Tablet or injection routes Long-term plan review Cardiovascular Health FDA CV risk indication SELECT trial backed 20% lower CV risk Metabolic Function Better glucose control Improved A1C Lipid panel gains Appetite Control Slows gastric emptying Reduces food noise Route-specific routine Lose weight with FDA-approved care

Wegovy is manufactured under FDA New Drug Application approval with large-scale pharmaceutical infrastructure

The UK GLP-1 programme appears to offer a more limited support model focused on workshops, community, and app-based content rather than 1-to-1 clinical coaching

Treatment decisions can therefore prioritize cardiorenal benefits, weight reduction, glycemic control, tolerability, and patient preferences rather than VTE risk [14, 22, 24, 25]